Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo

Heather Gornik, MD


Heather Gornik, MD
Department: Cardiovascular Medicine
Medical Director, Non-Invasive Vascular Lab
Location: Cleveland Clinic Main Campus
Mail Code J3-5
9500 Euclid Avenue
Cleveland, OH 44195
Type of Doctor:
Adults Only

Biographical Sketch

Heather L. Gornik, MD, is a Staff Physician in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, Section of Vascular Medicine at Cleveland Clinic’s Sydell and Arnold Miller Family Heart & Vascular Institute. She is also Medical Director of the Non-Invasive Vascular Laboratory of the Heart & Vascular Institute.

Dr. Gornik is board-certified in cardiovascular disease and has been certified in vascular disease by the American Board of Vascular Medicine. She is also fully trained in vascular ultrasound and is a registered vascular technologist.

In addition to her clinical duties, she serves as the Editor and Chief of the Journal of Vascular Medicine.

Specialty Interests: Fibromuscular dysplasia (FMD) and related disorders, peripheral artery disease and claudication, vascular ultrasound, non-invasive testing for vascular disease, venous thromboembolism, peripheral vascular disorders, Raynaud's phenomenon

Patient Volume: Dr. Gornik is internationally respected for her work related to fibromuscular dysplasia. She currently follows more than 400 Cleveland Clinic patients with this condition. Dr. Gornik is the Medical Director of one of the largest vascular laboratories in the country, which performed more than 33,000 studies at its main campus facilities in 2014.

Success Rates: the Section of Vascular Medicine at Cleveland Clinic is one of the most active Vascular Medicine programs in the United States. Our specialists treat patients with a wide variety of vascular problems, including all forms of arterial, venous, and lymphatic disorders, cardiovascular risk factor management, thrombotic disorders and hypercoagulable states and wound care. Success rates for specific procedures are available at

Education and Training: A native of Chicago, Dr. Gornik completed her undergraduate work at Johns Hopkins University, double majoring in public health and Spanish literature. She received a Master's degree in biostatistics from Johns Hopkins University and her medical degree from The University of Chicago/ Pritzker School of Medicine, where she graduated with honors. She continued her education at Harvard Medical School and the Massachusetts Institute of Technology, where she received a Master’s degree in clinical investigation. Dr. Gornik received an academic appointment as an instructor of medicine at Harvard Medical School.

Dr. Gornik completed a medical internship and residency at Brigham and Women's Hospital in Boston, where she became Chief Medical Resident. Her clinical training continued with a fellowship in cardiology from Brigham and Women's Hospital. In 2005, she completed a fellowship in vascular medicine at Brigham and Women's Hospital and was appointed to Cleveland Clinic as a staff cardiologist in the Tomsich Family Department of Cardiovascular Medicine, Sections of Clinical Cardiology and Vascular Medicine.

Research, Publications and Speaking: As a clinical investigator, Dr. Gornik has focused her research studies on optimizing the diagnosis and management of patients with peripheral vascular disorders.  She is involved in clinical trials of new treatments for patients with peripheral artery disease and deep vein thrombosis and is working on developing new tools to diagnose vascular disorders by noninvasive means. She is highly active in multiple research programs related to FMD.  In this regard, Dr. Gornik serves as the Cleveland Clinic site principal investigator for the United States Registry for Fibromuscular Dysplasia, and her interest in the care of patients with FMD has led to the creation of a dedicated clinic for patients with the condition.

Dr. Gornik has lectured frequently on her clinical specialty interests and her research work. She is author or co-author of book chapters in medical textbooks and she has published articles and abstracts in leading, peer-reviewed journals.

About Dr. Gornik: “It has been an exciting challenge for me to become immersed in the field of FMD research and clinical care. It is exciting to be able to take new discoveries about FMD immediately into the clinic to discuss with my patients to try to improve their health and quality of life.  Conversely, our observations from the clinic and also the great questions patients ask have helped to inform and motivate our research program.  My patients continue to motivate me and others in our FMD program to learn more about their disease, to find better ways to care for FMD patients, and to teach other healthcare providers about FMD so that patients with this under-recognized and underdiagnosed vascular disease can receive high-quality medical care no matter where they live.”

Leisure time activities: In her leisure time, Dr. Gornik enjoys spending time with family

Professional Highlights

  • Medical Director, Non-Invasive Vascular Laboratory
  • Board Of Directors, Intersocietal Accreditation Commission - Vascular Testing
  • President-Elect, Society for Vascular Medicine
  • Editor in Chief, Vascular Medicine

Education & Fellowships

Fellowship - Brigham & Women's Hospital
Vascular Medicine
Boston, MA
Fellowship - Brigham & Women's Hospital
Cardiovascular Disease
Boston, MA
Other - Brigham & Women's Hospital
Chief Medical Resident
Boston, MA
Residency - Brigham & Women's Hospital
Internal Medicine
Boston, MA
Internship - Brigham & Women's Hospital
Internal Medicine
Boston, MA
Medical School - University of Chicago Pritzker School of Medicine
Chicago, IL USA
Graduate - Johns Hopkins Bloomberg School of Public Health
Baltimore, MD USA
Undergraduate - Johns Hopkins University
Baltimore, MD USA

Specialty Interests

Fibromuscular dysplasia (FMD) and related disorders, peripheral artery disease and claudication, vascular ultrasound, non-invasive testing for vascular disease, venous thromboembolism, peripheral vascular disorders, Raynaud's phenomenon

Awards & Honors

  • 2010 American Red Cross of Greater Cleveland Hero Award Finalist
  • 2009 Founders Award, Fibromuscular Dysplasia Society of America
  • 2006 William F. Keating Award, American College of Cardiology
  • 2002 Chief Medical Resident, Brigham and Women's Hospital
  • 1999 Starfish Award for Compassionate Patient Care, Brigham and Women's Hospital
  • 1998 Arnold Dunne Medical Intern Award, Brigham and Women’s Hospital
  • 1996 Alpha Omega Alpha Honorary Medical Society
  • 1996 Calvin Fentress Research Award, University of Chicago

Additional Training

  • Vascular ultrasound credentials: registered vascular technologist
  • Registered physician in vascular interpretation

Innovations & Patents

Patent No. US 9,211,070 B2. Evaluation of Peripheral Arterial Disease in a Patient Using An Oscillometric Pressure Signal Obtained at a Lower Extremity of the Patient.  


  • Fellow, American College of Cardiology
  • Fellow, American Heart Association
  • Fellow, Society for Vascular Medicine
  • Society for Vascular Ultrasound


Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 5/3/2016, Dr. Gornik has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Royalty Payments. Dr. Gornik receives or has the right to receive royalty payments for inventions or discoveries commercialized through the companies shown below:

  • FlexLife Health, Inc. (Financial Interest is donated)
  • Summit Doppler Systems, Inc.

Equity. Dr. Gornik owns stock or stock options in the following companies for activities as a founder, inventor, discover, developer:

  • FlexLife Health, Inc. (Financial Interest is donated)

Right to Future Distribution of Cleveland Clinic Financial Interest. Dr. Gornik may receive future financial benefits from the Cleveland Clinic for inventions or discoveries commercialized through the companies shown below:

  • FlexLife Health, Inc. (Financial Interest is donated)

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English

Patient Satisfaction Reviews

Learn About Our Survey


The Patient Satisfaction Rating is an average of all responses to the care provider related questions shown below from our nationally-recognized Press Ganey Patient Satisfaction Survey. Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.

Responses are measured on a scale of 1 to 5 with 5 being the best score.

The comments are submitted by patients and reflect their views and opinions. The comments are not endorsed by and do not necessarily reflect the views of Cleveland Clinic.